---
title: "COMISSIONG DAVID A. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/5eff141e-a99a-5482-8d84-10a280cd1ca4
json: https://whiteintel.dev/api/public/dossier/5eff141e-a99a-5482-8d84-10a280cd1ca4
identifier: icij:icijol-110093071
risk: Low
source: WhiteIntel corporate-ownership graph
---

# COMISSIONG DAVID A.

**Type:** Organization  
**Identifier:** `icij:icijol-110093071`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/5eff141e-a99a-5482-8d84-10a280cd1ca4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/5eff141e-a99a-5482-8d84-10a280cd1ca4  

## Ownership & control

### Holdings / subsidiaries

- **SUPERIOR PHARMACEUTICAL COMPANY LTD.** (director of) — https://whiteintel.dev/entity/3f065c5f-b159-537f-b0d0-abdb1466c762

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/110093071

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **COMISSIONG DAVID A.**. Human view: https://whiteintel.dev/entity/5eff141e-a99a-5482-8d84-10a280cd1ca4 · Structured JSON: https://whiteintel.dev/api/public/dossier/5eff141e-a99a-5482-8d84-10a280cd1ca4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._